XML 19 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Statement of Cash Flows [Abstract]    
Net loss $ (43,484) $ (202,688)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 158,002 88,941
Impairment charges of intangible assets 0 319,246
Provision for bad debt expense 754 3,503
Amortization of premium/discount on purchased securities 96 218
Gain on disposal of fixed assets (99) 0
Non-cash equity-based compensation expense 14,599 18,058
Non-cash IPR&D expense 0 945
Loss on debt extinguishment 35,922 9,830
Amortization of debt discount and debt issuance costs 11,824 10,600
Gains on marketable securities, net (1) (255)
Change in fair value of contingent consideration (49,175) (47,142)
Deferred income taxes 43,747 (146,682)
Gain on sale of the CBR business (89,581) 0
Transaction costs (14,111) 0
Changes in operating assets and liabilities:    
Accounts receivable, net 7,175 (8,889)
Inventories 3,587 (600)
Prepaid and other current assets 1,101 (1,409)
Accounts payable and accrued expenses (4,280) 29,977
Deferred revenues 8,658 14,134
Other assets and liabilities 159 (1,139)
Net cash provided by operating activities 84,893 86,648
Cash flows from investing activities:    
Proceeds from sales or maturities of marketable securities 60,146 279,526
Purchase of marketable securities (64,400) (110,894)
Acquisition of Intrarosa intangible asset 0 (55,800)
Proceeds from the sale of the CBR business 519,303 0
Capital expenditures (1,913) (6,573)
Net cash provided by investing activities 513,136 106,259
Cash flows from financing activities:    
Long-term debt principal payments (475,000) (328,125)
Proceeds from 2022 Convertible Notes 0 320,000
Payment to repurchase 2019 Convertible Notes 0 (191,480)
Payment of premium on debt extinguishment (28,054) 0
Proceeds to settle warrants 0 323
Payment of convertible debt issuance costs 0 (9,553)
Payments of contingent consideration (87) (165)
Proceeds from the exercise of common stock options 2,635 2,350
Payments of employee tax withholding related to equity-based compensation (2,632) (2,588)
Net cash used in financing activities (503,138) (209,238)
Net increase (decrease) in cash, cash equivalents, and restricted cash 94,891 (16,331)
Cash, cash equivalents, and restricted cash related to discontinued operations 0 (50,017)
Cash, cash equivalents, and restricted cash at beginning of the period 192,770 276,898
Cash, cash equivalents, and restricted cash at end of the period 287,661 210,550
Supplemental data for cash flow information:    
Cash paid for taxes 5,041 3,565
Cash paid for interest 43,546 50,892
Non-cash investing and financing activities:    
Fair value of common stock issued in connection with the acquisition of the Intrarosa intangible asset 0 12,555
Contingent consideration accrued for the acquisition of the Intrarosa intangible asset $ 0 $ 9,300